Show simple item record

dc.contributor.authorDangoor, A
dc.contributor.authorJoffe, J
dc.contributor.authorJanuszewski, A
dc.contributor.authorHall, M
dc.contributor.authorBoard, R
dc.contributor.authorMansi, J
dc.contributor.authorAhmed, S
dc.contributor.authorArcher, C
dc.contributor.authorMoe, M
dc.contributor.authorJones, A
dc.contributor.authorGrumett, S
dc.contributor.authorBaird, Richard
dc.contributor.authorGriffiths, R
dc.contributor.authorMichie, C
dc.contributor.authorKarapanagiotou, E
dc.contributor.authorTurnbull, S
dc.contributor.authorYoung, A
dc.contributor.authorAgarwal, R
dc.contributor.authorHill, M
dc.contributor.authorOpenshaw, M
dc.contributor.authorEarl, Helena
dc.contributor.authorCunningham, D
dc.contributor.authorSelby, P
dc.contributor.authoron behalf of the Association of Cancer Physicians, UK
dc.date.accessioned2017-02-02T12:13:19Z
dc.date.available2017-02-02T12:13:19Z
dc.date.issued2016-11-16
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/262233
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.titleResponse to "Cancer drugs, survival, and ethics" by the Association of Cancer Physicians
dc.typeArticle
prism.issueIdentifieri5792
prism.numberrr-13
prism.publicationDate2016
prism.publicationNameThe BMJ
prism.volume355
dc.identifier.doi10.17863/CAM.7486
dcterms.dateAccepted2016-11-09
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-11-16
dc.contributor.orcidBaird, Richard [0000-0001-7071-6483]
dc.contributor.orcidEarl, Helena [0000-0003-1549-8094]
dc.publisher.urlhttp://www.bmj.com/content/355/bmj.i5792/rr-13
rioxxterms.typeJournal Article/Review
dc.identifier.urlhttp://www.bmj.com/content/355/bmj.i5792/rr-13
cam.descriptionThis is a response to Wise (2016) Cancer drugs, survival, and ethics in BMJ 355:i5792 http://doi.org/10.1136/bmj.i5792.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record